Advertisement

Topics

Real-world data prove efficacy of Eisai and Bial's epilepsy treatment

03:30 EDT 6 Sep 2017 | Pharmafile

Bial and Eisai have released real-world data which support the efficacy of Zebinix (eslicarbazepine acetate) in the treatment of partial-onset epilepsy in adults, as part of a post-market study of more than 2,000 patients using the drug, making it one of the largest-ever studies of its kind in the disease area.

read more

Original Article: Real-world data prove efficacy of Eisai and Bial's epilepsy treatment

NEXT ARTICLE

More From BioPortfolio on "Real-world data prove efficacy of Eisai and Bial's epilepsy treatment"

Quick Search
Advertisement
 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...